Category: us corporate news

us corporate news

Alexander’s Inc. to Sell Rego Park I Property to Northwell Health for $235.5 Million, Expects $147 Million Gain

Minichart

March 9, 2026

Alexander's, Inc. Announces Sale of Rego Park I Property ...

Continue Reading 0

us corporate news

Jefferies Responds to Western Alliance Lawsuit Over First Brands Loans and Discloses Limited Exposure to MFS Losses

Minichart

March 9, 2026

Jefferies Financial Group Responds to Western Alliance Lawsu...

Continue Reading 0

us corporate news

News Corporation Announces Share Buy-Back Program Updates and Key Details – March 2026 Filing

Minichart

March 9, 2026

News Corporation Announces Ongoing \$1 Billion Stock Buyback...

Continue Reading 0

us corporate news

Korn Ferry Reports Strong Q3 FY2026 Results: 7% Revenue Growth, Higher Earnings, and Positive Outlook

Minichart

March 9, 2026

Korn Ferry Q3 FY2026 Financial Results: Detailed Investor Up...

Continue Reading 0

us corporate news

W&T Offshore Announces Preliminary 2025 Financial Results: Net Loss, Production, Reserves, and Liquidity Overview 123

Minichart

March 9, 2026

W&T Offshore 2025 Preliminary Financial Results - Investor R...

Continue Reading 0

us corporate news

Ionis Pharmaceuticals Announces Board Changes: Parshall and Wender to Retire, Reikes Rejoins in 2026

Minichart

March 9, 2026

Ionis Pharmaceuticals Announces Key Board Changes Ionis ...

Continue Reading 0

us corporate news

Gulfport Energy Announces CEO Departure and Interim Leadership Team Formation in 2026

Minichart

March 9, 2026

Gulfport Energy Announces Leadership Transition and Maintain...

Continue Reading 0

us corporate news

Fluor Corporation SEC 8-K Filing March 3, 2026: Company Details, Address, and XBRL Data Summary

Minichart

March 9, 2026

Fluor Corporation Announces Board Changes and Director Appoi...

Continue Reading 0

us corporate news

Cartesian Therapeutics Reports 2025 Financial Results, Advances Descartes-08 Cell Therapy in Autoimmune Diseases and Myasthenia Gravis Phase 3 Trial

Minichart

March 9, 2026

Cartesian Therapeutics Reports Full Year 2025 Financial Resu...

Continue Reading 0

us corporate news

enGene Reports Q1 2026 Results, Advances Detalimogene for Bladder Cancer with Strong Cash Position and FDA Milestones 12

Minichart

March 9, 2026

enGene Holdings Inc. Reports First Quarter 2026 Financial Re...

Continue Reading 0

Category: us corporate news

Join Our Investing Seminar